New approaches to the chemotherapy of glioblastoma: investigations on doxorubicin nanoparticles, inhibition of PDGF receptors and kinesin Eg5, with emphasis on confocal laser-scanning microscopy

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Unknown venue

• Publication date

  2006-09-17

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The conformational stability of a non-covalent dimer of a platelet-derived growth factor-B mutant lacking the two cysteines involved in interchain disulfide bonds.

  2009cited by this paper
• [Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen].

  2007cited by this paper
• Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells

  2006cited by this paper
• IN VIVO AND IN VITRO

  2006cited by this paper
• Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity

  2005cited by this paper
• Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.

  2005cited by this paper
• Disruption of intermolecular disulfide bonds in PDGF-BB dimers by N-acetyl-L-cysteine does not prevent PDGF signaling in cultured hepatic stellate cells.

  2005cited by this paper
• Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage.

  2005cited by this paper
• Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5.

  2005cited by this paper
• Synthesis and Biological Evaluation of Novel Eg5 Inhibitors

  2005cited by this paper
• Structural and functional specificities of PDGF‐C and PDGF‐D, the novel members of the platelet‐derived growth factors family

  2005cited by this paper
• Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.

  2005cited by this paper
• Chemotherapy-induced peripheral neuropathy.

  2005cited by this paper
• Multicentre phase II study of imatinib mesylate in patients with recurrent glioblastoma: An EORTC: NDDG/BTG Intergroup Study.

  2004cited by this paper
• Imatinib Mesylate Is a Potent Inhibitor of the ABCG2 (BCRP) Transporter and Reverses Resistance to Topotecan and SN-38 in Vitro

  2004cited by this paper
• Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains.

  2004cited by this paper
• Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH

  2004cited by this paper
• Imatinib mesylate inhibits platelet-derived growth factor receptor phosphorylation of melanoma cells but does not affect tumorigenicity in vivo.

  2004cited by this paper
• Antitumor activity of a kinesin inhibitor.

  2004cited by this paper
• Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.

  2004cited by this paper
• P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylate

  2004cited by this paper
• A Potential Oncogenic Activity of Platelet-Derived Growth Factor D in Prostate Cancer Progression

  2004cited by this paper
• Mitogenesis in Glioblastoma Multiforme Cell Lines: A Role for NGF and its TrkA Receptors

  2004cited by this paper
• Imatinib (STI571) plus hydroxyurea: Safety and efficacy in pre-treated, progressive glioblastoma multiforme (GBM) patients (pts).

  2004cited by this paper
• The use of the MTT assay to study drug resistance in fresh tumour samples.

  2003cited by this paper
• Microtubules, microtubule-interfering agents and apoptosis

  2003cited by this paper
• Isolation and characterization of cerebral microvascular pericytes.

  2003cited by this paper
• A novel action of terpendole E on the motor activity of mitotic Kinesin Eg5.

  2003cited by this paper
• Imatinib in small cell lung cancer.

  2003cited by this paper
• Direct Evidence That Polysorbate-80-Coated Poly(Butylcyanoacrylate) Nanoparticles Deliver Drugs to the CNS via Specific Mechanisms Requiring Prior Binding of Drug to the Nanoparticles

  2003cited by this paper
• Drug delivery to brain via the blood-brain barrier.

  2002cited by this paper
• Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma.

  2002cited by this paper
• Role of KIFC3 motor protein in Golgi positioning and integration

  2002cited by this paper
• [Differential regulation of expression of PDGF receptors on corneal epithelial cells].

  2002cited by this paper
• Drug sensitivity assay for leukaemic cells by flow cytometry.

  2002cited by this paper
• Platelet-derived growth factor-B and -C and active alpha-receptors in medulloblastoma cells.

  2002cited by this paper
• Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.

  2002cited by this paper
• Platelet-derived growth factor D: tumorigenicity in mice and dysregulated expression in human cancer.

  2002cited by this paper
• Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines

  2002cited by this paper
• Pharmacology of imatinib (STI571).

  2002cited by this paper
• Chromosome Dynamics: New Light on Aurora B Kinase Function Dispatch

  2002cited by this paper
• A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2).

  2001cited by this paper
• Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints

  2001cited by this paper
• Platelet-derived growth factor C (PDGF-C), a novel growth factor that binds to PDGF alpha and beta receptor.

  2001cited by this paper
• Chitosan nanoparticles as delivery systems for doxorubicin.

  2001cited by this paper
• PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.

  2001cited by this paper
• Past and future of the mitotic spindle as an oncology target.

  2001cited by this paper
• KIFC3, a microtubule minus end–directed motor for the apical transport of annexin XIIIb–associated Triton-insoluble membranes

  2001cited by this paper
• PDGF-D, a new protease-activated growth factor

  2001cited by this paper
• High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

  2000cited by this paper
• CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint

  2000cited by this paper
• Microtubule motors in mitosis

  2000cited by this paper
• The Rab6‐binding kinesin, Rab6‐KIFL, is required for cytokinesis

  2000cited by this paper
• PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.

  2000cited by this paper
• From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents

  2000cited by this paper
• Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class.

  2000cited by this paper
• Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system.

  2000cited by this paper
• New paradigms for the treatment of cancer: the role of anti-angiogenesis agents.

  2000cited by this paper
• CENP-E as an essential component of the mitotic checkpoint in vitro.

  2000cited by this paper
• Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR.

  1999cited by this paper
• Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines

  1999cited by this paper
• Gelatin Behaviour in Dilute Aqueous Solution: Designing a Nanoparticulate Formulation

  1999cited by this paper
• Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles

  1999influential reference
• Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.

  1999cited by this paper
• Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles

  1999cited by this paper
• Phase I and pharmacologic study of the tyrosine kinase inhibitor SU101 in patients with advanced solid tumors.

  1999cited by this paper
• Phospholipase C-gamma as a signal-transducing element.

  1999cited by this paper
• Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.

  1999cited by this paper
• A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.

  1999cited by this paper
• In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action.

  1999cited by this paper
• A marine natural product inhibitor of kinesin motors.

  1998cited by this paper
• [Inhibition of fibroblast growth factor receptor 1 expression in human glioblastoma cell contributes to the cell growth suppression].

  1998cited by this paper
• [A study on the relationship among activity of PDGFBB autocrine loop, cell proliferation and apoptosis in human glioma cells].

  1998cited by this paper
• Structure-activity relationships for 1-phenylbenzimidazoles as selective ATP site inhibitors of the platelet-derived growth factor receptor.

  1998cited by this paper
• Targeting of proteins to the Golgi apparatus

  1998cited by this paper
• Microtubules and actin filaments: dynamic targets for cancer chemotherapy.

  1998cited by this paper
• Functional Importance of Platelet-derived Growth Factor (PDGF) Receptor Extracellular Immunoglobulin-like Domains

  1997cited by this paper
• Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF.

  1997cited by this paper
• Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.

  1997cited by this paper
• Phosphorylation site-specific inhibition of platelet-derived growth factor beta-receptor autophosphorylation by the receptor blocking tyrphostin AG1296.

  1997cited by this paper
• Coupling cell division and cell death to microtubule dynamics.

  1997cited by this paper
• Integrins and anoikis.

  1997cited by this paper
• Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.

  1997cited by this paper
• Deregulation of the platelet-derived growth factor β-chain gene via fusion with collagen gene COL1A1 in dermatof ibrosarcoma protuberans and giant-cell fibroblastoma

  1997cited by this paper
• CENP-E Function at Kinetochores Is Essential for Chromosome Alignment

  1997cited by this paper
• The design plan of kinesin motors.

  1997cited by this paper
• Anchorage-dependent Cell Cycle Progression

  1997cited by this paper
• Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas.

  1996cited by this paper
• Engineering green fluorescent protein for improved brightness, longer wavelengths and fluorescence resonance energy transfer.

  1996cited by this paper
• XKCM1: a Xenopus kinesin-related protein that regulates microtubule dynamics during mitotic spindle assembly.

  1996cited by this paper
• Localization of Platelet-derived Growth Factor-stimulated Phosphorylation Cascade to Caveolae (*)

  1996cited by this paper
• A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells.

  1996cited by this paper
• The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways.

  1996cited by this paper
• Biology of the multidrug resistance-associated protein, MRP.

  1996cited by this paper
• Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and Vinblastine

  1996cited by this paper
• Inhibitory DNA ligands to platelet-derived growth factor B-chain.

  1996cited by this paper
• Platelet-derived Growth Factor Stimulates Protein Kinase A through a Mitogen-activated Protein Kinase-dependent Pathway in Human Arterial Smooth Muscle Cells (*)

  1996cited by this paper
• Identification of a Putative Syp Substrate, the PDGFβ Receptor (*)

  1995cited by this paper
• Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop

  1995cited by this paper
• Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics

  1995cited by this paper

• New tariquidar-like ABCB1 modulators in cancer chemotherapy:Preclinical pharmacokinetic, pharmacodynamic investigations and computational studies

  2010cites this paper